-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
HCW Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- HCW Biologics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.69M, a 27.3% increase year-over-year.
- HCW Biologics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$37.1M, a 79.9% decline year-over-year.
- HCW Biologics Inc. annual Operating Income (Loss) for 2023 was -$25.7M, a 70.6% decline from 2022.
- HCW Biologics Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 12.8% decline from 2021.
- HCW Biologics Inc. annual Operating Income (Loss) for 2021 was -$13.4M, a 130% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)